Join the ACTA STInG Trials Webinar Series: Seamless Phase 2/3 Designs in Oncology!
Starting on Wed Nov 8th, 2023, from 16:00:00-17:00 AEDT, this online event will provide valuable insights into seamless Phase 2/3 designs in oncology.
Among a number of possible adaptive features, common designs involve arm dropping for futility, sample size re-estimation, and population enrichment. This webinar will cover the major statistical considerations for designing and analysing seamless phase 2/3 studies in oncology, including:
• Planning interim analyses with objective response rate (ORR), progression-free survival (PFS) and overall survival (OS) endpoints
• Controlling type I error in the context of interim analyses and multiple endpoints
• The role of simulations in finalising the design
• Regulatory experience
Register now and mark your calendar for this insightful webinar series!
James Matcham
VP Statistical Strategic Consulting, Therapeutic Development Team
Cytel (Australia) Pty Ltd
Latest Resources
-
-
Webinar recording: Historical and non-concurrent controls in clinical trials
-
STInG Chat – ‘Securing Funding: Tips and Tricks for Investigator Grants’
-
Webinar recording: Introduction to Git for Clinical Statisticians
-
The processes involved in a Data and Safety Monitoring Board/Committee with special reference to the role of the various statisticians
-
ACTA STInG grant advice for trial statisticians
-
ACTA STInGChat – ‘Climbing the Career Cascade’
-
Seamless Phase 2_3 Trials in Oncology
-
Career paths for academic biostatisticians
-
ACTA STInG: N-of-1 Trials Webinar Series – Webinar 2
-
ACTA STInG: N-of-1 Trials Webinar Series – Webinar 1
-
Effective strategies to manage data integrity risks webinar
-
The Data Lifecycle: Ethical use of data webinar
-
Transparency in data analyses webinar
-
Webinar PIONEERing estimands in Clinical Research
-
Estimands: Not just a statistical issue
-
Resource for trial statisticians planning to apply for an academic promotion
-
Guidance on Peer Reviewing the Statistical Aspects of a Medical Paper
-
Protocols and Statistical Analysis Plans (SAPs) for Adaptive and Platform Trials
-
Webinar: Estimands in Oncology – How and Why
-
Seven steps for statistical success in clinical trials [Good clinical practice guidelines] Part 2
-
Seven steps for statistical success in clinical trials [Good clinical practice guidelines] Part 1
-
Data and Safety Monitoring Boards Webinar Series: Statistical Principles
-
Data and Safety Monitoring Boards Webinar Series: How to plan well and be prepared for the unexpected
-
Joint webinar on estimands in clinical trials
-
Statistical Analysis Plan (SAP)
-
Data Safety and Monitoring Boards (DSMB) for Adaptive Trials Webinar video
-
Bayesian adaptive randomised clinical trials flyer
-
ACTA STInG Notes from Members’ meeting, October 2019
-
ACTA STInG 2017 Member Survey Results
-
ACTA STInG Submission to the NHMRC Structural Review
Latest Events
-
Webinar: Introduction to Git for Clinical Statisticians
-
ACTA STInG – Stata and R Markdown Demonstrations
-
ACTA STInG 3 part webinar series on Data Transparency (DT)
-
Clinical Trials 2021: National Tribute and Award Ceremony
-
Clarifying clinical trial aims and analysis using the estimands framework
-
Practical approaches to Adaptive Trial Simulation
-
An Introduction to Adaptive Trial Designs
-
Seven steps for statistical success in clinical trials [Good clinical practice guidelines] Part 2
-
Seven steps for statistical success in clinical trials [Good clinical practice guidelines] Part 1
-
Statistical principles – Data and Safety Monitoring Boards Webinar Series
-
How to plan well and be prepared for the unexpected – Data and Safety Monitoring Boards Webinar Series
-
Webinar: Data Safety and Monitoring Boards for Adaptive Trials
-
Bayesian Adaptive Randomised Clinical Trials Workshop, Sydney
-
Bayesian Adaptive Randomised Clinical Trials Workshop, Melbourne
-
Bayesian Adaptive Trials Workshops: Perth